Cargando…
High frequency of hyperglycaemia observed during CAR T‐cell treatment
Autores principales: | Tienstra, Marieke, de Boer, Janneke W., van Doesum, Jaap A., van Meerten, Tom, van Dijk, Peter R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092516/ https://www.ncbi.nlm.nih.gov/pubmed/36209376 http://dx.doi.org/10.1111/dme.14969 |
Ejemplares similares
-
Semi-automated (18)F-FDG PET segmentation methods for tumor volume determination in Non-Hodgkin lymphoma patients: a literature review, implementation and multi-threshold evaluation
por: Keijzer, Kylie, et al.
Publicado: (2023) -
Inflammatory reactions mimic residual or recurrent lymphoma on [(18)F]FDG-PET/CT after CD19-directed CAR T-cell therapy
por: de Boer, Janneke W., et al.
Publicado: (2023) -
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities
por: de Boer, Janneke W., et al.
Publicado: (2023) -
Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: Diagnosis and Treatment
por: van Doesum, Jaap A., et al.
Publicado: (2021) -
Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands
por: van Doesum, Jaap, et al.
Publicado: (2020)